Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 22350791)

1.

Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma.

Jarai T, Maasz G, Burian A, Bona A, Jambor E, Gerlinger I, Mark L.

Pathol Oncol Res. 2012 Jul;18(3):623-8. doi: 10.1007/s12253-011-9486-4. Epub 2012 Feb 15.

PMID:
22350791
2.

Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.

Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, Tsai MH, Huang SH, Lin CW.

Anal Chim Acta. 2010 Nov 29;681(1-2):41-8. doi: 10.1016/j.aca.2010.09.030. Epub 2010 Sep 25.

PMID:
21035601
3.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
4.

Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers.

Jancsik VA, Gelencser G, Maasz G, Schmidt J, Molnar GA, Wittmann I, Olasz L, Mark L.

Pathol Oncol Res. 2014 Jul;20(3):591-5. doi: 10.1007/s12253-013-9736-8. Epub 2013 Dec 17.

PMID:
24343817
5.

Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.

Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, El-Naggar AK.

Int J Oncol. 2007 Mar;30(3):743-9.

PMID:
17273777
6.

Proteomic identification of serum biomarkers for head and neck cancer surveillance.

Gourin CG, Zhi W, Adam BL.

Laryngoscope. 2009 Jul;119(7):1291-302. doi: 10.1002/lary.20279.

PMID:
19444892
7.

Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.

Mol Cell Proteomics. 2012 Nov;11(11):1404-15. doi: 10.1074/mcp.M112.020933. Epub 2012 Aug 23.

8.

Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.

Drake RR, Cazare LH, Semmes OJ, Wadsworth JT.

Expert Rev Mol Diagn. 2005 Jan;5(1):93-100. Review.

PMID:
15723595
9.

Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis.

Dowling P, Wormald R, Meleady P, Henry M, Curran A, Clynes M.

J Proteomics. 2008 Jul 21;71(2):168-75. doi: 10.1016/j.jprot.2008.04.004. Epub 2008 May 1.

PMID:
18617144
10.

Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.

Lallemant B, Evrard A, Combescure C, Chapuis H, Chambon G, Raynal C, Reynaud C, Sabra O, Joubert D, Hollande F, Lallemant JG, Lumbroso S, Brouillet JP.

BMC Cancer. 2009 Oct 18;9:370. doi: 10.1186/1471-2407-9-370.

11.

Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.

Roblick UJ, Bader FG, Hammarstedt L, Habermann JK, Hellman U, Becker S, Sundmacker A, Gemoll T, Zimmermann K, Auer G, Munck-Wikland E.

Acta Oncol. 2008;47(8):1493-501. doi: 10.1080/02841860802314696.

PMID:
18759147
12.
13.

Salivary proteomics for oral cancer biomarker discovery.

Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT.

Clin Cancer Res. 2008 Oct 1;14(19):6246-52. doi: 10.1158/1078-0432.CCR-07-5037.

14.

Salivary and serum proteomics in head and neck carcinomas: before and after surgery and radiotherapy.

Vidotto A, Henrique T, Raposo LS, Maniglia JV, Tajara EH.

Cancer Biomark. 2010-2011;8(2):95-107. doi: 10.3233/CBM-2011-0205.

PMID:
21896997
15.

Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma.

Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B, Minucci A, Paludetti G, Giardina B.

Head Neck. 2007 Jul;29(7):648-54.

PMID:
17274058
16.

Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.

Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, Favrot MC.

Clin Cancer Res. 2007 Feb 15;13(4):1179-85.

17.

Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.

Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, Bogumil R, Moller U, Osterloh D, Halbhuber KJ, von Eggeling F.

Mol Cell Proteomics. 2003 Jul;2(7):443-52. Epub 2003 Jun 23.

18.

Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform.

Shintani S, Hamakawa H, Ueyama Y, Hatori M, Toyoshima T.

Int J Oral Maxillofac Surg. 2010 Jan;39(1):68-74. doi: 10.1016/j.ijom.2009.10.001. Epub 2009 Nov 5.

PMID:
19896329
19.

Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.

Jou YJ, Lin CD, Lai CH, Tang CH, Huang SH, Tsai MH, Chen SY, Kao JY, Lin CW.

Clin Chim Acta. 2011 Jul 15;412(15-16):1357-65. doi: 10.1016/j.cca.2011.04.004. Epub 2011 Apr 8.

PMID:
21497587
20.

Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue.

Li B, Chang J, Chu Y, Kang H, Yang J, Jiang J, Ma H.

Cancer Lett. 2012 Jun 1;319(1):118-24. doi: 10.1016/j.canlet.2011.12.037. Epub 2012 Jan 15.

PMID:
22252117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk